RECENT NEWS

Visit the WFH News page to find out more about the events and developments that are making a difference today.

WFH Twinning Program welcomes seven new partnerships in 2026 header - EN

WFH Twinning Program welcomes seven new partnerships in 2026

The World Federation of Hemophilia (WFH) is pleased to announce the addition of seven new partnerships to the WFH Twinning Program. Designed to fund short-term collaborative partnerships between patient organizations, medical professionals, and youth leaders from around the world, the WFH Twinning Program enhances capacity building and sustainability through the exchange of knowledge and expertise. This year, three new Hemophilia Organization Twins (HOT) and four Hemophilia Treatment Centre (HTC) twins are joining the WFH.

Also available in: Français Español

WFH Twinning Program partnerships around the world have improved diagnosis and treatment, enriched the knowledge of healthcare professionals (HCPs) caring for people with bleeding disorders, enhanced outreach initiatives, facilitated resource sharing, increased government support for bleeding disorders through advocacy initiatives, and strengthened patient organizations through capacity building. Established more than 30 years ago, the WFH Twinning Program has supported 286 partnerships across 129 countries.

Hemophilia Organization Twinning (HOT) strengthens patient organizations and promotes organizational development  to enhance advocacy and support services for people living with bleeding disorders. The following are the three new HOT twinning partnerships launched this year:

Emerging partner: Association Guinéenne de Lutte contre l’Hémophilie et Autres Maladies Hémorragique Established partner: Association française des hémophiles, Île-de-France
Guinée – Île-de-France (France)

Twins

Twinning objectives

Guinée – Île-de-France (France)

  • Strengthen organization governance
  • Increase the representation of women and girls with bleeding disorders (WGBD) and youth in the local community
  • Enhance patient education on bleeding disorders
  • Train national member organization (NMO) board members in advocacy and enhance stakeholder engagement
Emerging partner: Botswana Inherited Bleeding Disorders Association Established partner: Pacific Northwest Bleeding Disorders
Botswana – Pacific Northwest (U.S.A)

Twins

Twinning objectives

Botswana – Pacific Northwest (U.S.A)

  • Emerging partner: Botswana Inherited Bleeding Disorders Association
  • Established partner: Pacific Northwest Bleeding Disorders
  • Foster and develop youth leadership
  • Establish a core parent group
  • Increase NMO visibility
  • Expand and improve patient registry
  • Increase outreach and education
  • Advocate for the adoption of comprehensive national treatment guidelines
Emerging partner: Cambodian Hemophilia Association Established partner: Haemophilia Foundation of Australia
Cambodia – Australia

Twins

Twinning objectives

Cambodia – Australia

  • Emerging partner: Cambodian Hemophilia Association
  • Established partner: Haemophilia Foundation of Australia
  • Build and strengthen organizational capacities such as governance, communication and leadership
  • Enhance patient education and patient engagement
  • Leverage data for advocacy
  • Increase funding
  • Strengthen relationships with stakeholders

Hemophilia Treatment Centre (HTC) Twinning helps HCPs provide adequate diagnosis, treatment and care for people living with bleeding disorders. This year, the program welcomed four new HTC partnerships:

Emerging partner: Service Hématologie CHU Ignace Deen de Conakry Established partner: Hôpital Necker
Conakry (Guinea) – Paris (France)

Twins

Twinning objectives

Conakry (Guinea) – Paris (France)

  • Emerging partner:
    Service Hématologie CHU Ignace Deen de Conakry
  • Established partner: Hôpital Necker
  • Improve diagnosis, treatment and monitoring
  • Create a digital registry
  • Produce educational resources
  • Decentralize care
Emerging partner: Hemophilia Treatment Centre Clinical Centre University of Sarajevo Established partner: Centre for Thrombosis and Hemorrhagic Diseases, IRCCS Humanitas Research Hospital
Sarajevo (Bosnia and Herzegovina) – Milan (Italy)

Twins

Twinning objectives

Sarajevo (Bosnia and Herzegovina) – Milan (Italy)

Emerging partner: Hemophilia Treatment Centre Clinical Centre University of Sarajevo

Established partner: Centre for Thrombosis and Hemorrhagic Diseases, IRCCS Humanitas Research Hospital

  • Deliver standardized, high-quality, multidisciplinary care
  • Operate reliable laboratory and data systems
  • Expand on the HTC’s role as a national reference centre with a greater reach and improve referral pathways
Emerging partner: Dr Margono Soekarjo Hospital Established partner: Van Creveldkliniek Department of Benign Hematology University Medical Centre Utrecht
Purwokerto (Indonesia) – Utrecht (Netherlands)

Twins

Twinning objectives

Purwokerto (Indonesia) – Utrecht (Netherlands)

  • Emerging partner:
    Dr Margono Soekarjo Hospital
  • Established partner:
    Van Creveldkliniek Department of Benign Hematology University Medical Centre Utrecht

Increase awareness among general practitioner physicians and first line HCPs

  • Train the multidisciplinary team
  • Collaborate with lab specialists and strengthen diagnostic capacity
  • Implement and optimize local protocols and standard operating procedures (SOPs)
  • Educate PWBDs in the community
  • Implement a telemedicine program

 

Karachi (Pakistan) – Geneva (Switzerland)

Twins

Twinning objectives

Karachi (Pakistan) – Geneva (Switzerland)

  • Emerging partner: Hemophilia Welfare Society Karachi (HWSK)
  • Established partner: University Hospitals of Geneva
  • Increase knowledge and capacity among HCPs
  • Improve laboratory diagnosis
  • Standardize clinical management protocols
  • Collaborate on joint research publications

The WFH looks forward to supporting these new partnerships and collaborating effectively with them to have a positive impact on lives of people with bleeding disorders worldwide.

To find out more about the WFH Twinning Program, click here.

The WFH Twinning Program is supported by exclusive funding from Pfizer and Sanofi.

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.